Successful reuse of software components:a report from the open source perspective

A promising way of software reuse is component-based software development (CBSD). There is an increasing number of OSS products available that can be freely used in product development. However, OSS communities themselves have not yet taken full advantage of the “reuse mechanism”. Many OSS projects duplicate effort and code, even when sharing the same application domain and topic. One successful counter-example is the FFMpeg multimedia project, since several of its components are widely and consistently reused into other OSS projects. This paper documents the history of the libavcodec library of components from the FFMpeg project, which at present is reused in more than 140 OSS projects. Most of the recipients use it as a blackbox component, although a number of OSS projects keep a copy of it in their repositories, and modify it as such. In both cases, we argue that libavcodec is a successful example of reusable OSS library of components

Hereditary tyrosinaemia. Clinical, enzymatic, and pathological study of an infant with the acute form of the disease.

A clinical, enzymatic, and pathological study of an infant with the acute form of hereditary tyrosinaemia is presented. Treatment with a diet low in methionine, tyrosine, and phenylalanine was unsuccessful. A selection of specific and nonspecific hepatic enzymes, obtained at necropsy within one hour of the infant's death at 9 1/2 weeks, were studied to try to throw light on the basic defect. The major pathological findings were those of a peculiar hepatic fibrosis associated with bile retention and an abnormal grouping of hepatocytes, islet-cell hyperplasia of the pancreas, and dilatation of the proximal renal tubules. Death was precipitated by bronchopneumonia and liver failure. The difficulty in diagnosing the acute form of tyrosinaemia is pointed out, especially in differentiating it from hereditary galactosaemia (transferase deficiency) and hereditary fructosaemia. All three may present with the same clinical symptoms and liver lesions, and the distinction must be made by enzyme studies and by therapeutic trial